Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters.
Epidemiological studies have shown that the haemostatic parameters Fibrinogen (Fg), Factor VII (F VII), Factor VIII (F VIII), von Willebrand factor (vWF), Tissue Plasminogen Activator (t-PA), Plasminogen Activator Inhibitors (PAI) are risk factors/markers of ischemic cardiovascular disease. Ferritin (sFER) and Leukocytosis have also been implicated. In the present study we have followed the levels of fibrinogen, von Willebrand factor and thrombomodulin in relation to lipids, iron and the appearance of atherosclerotic lesions in New Zealand rabbits fed with a cholesterol enriched diet for a two-month period compared with a group of control rabbits. Hematocrit and white blood cell count (WBC) were measured in parallel. In hyperchlesterolemic rabbits the levels of fibrinogen and von Willebrand factor increased progressively, showing a positive correlation with the increasing cholesterol levels. There was an increase in soluble thrombomodulin beginning at the eighth week of study. In addition, these animals showed gross intimal atherosclerotic lesions in the whole extension of their aortas. Immunohistochemical studies showed the presence of fibrin(ogen) related antigen throughout the arterial wall and in the central portions of the atheromas. In the control group there was no formation of atherosclerotic plaques and all haemostatic, haematological and biochemical parameters were within the normal range. WBC and sFER levels were unaffected in both groups. Our results show that increased levels of fibrinogen and von Willebrand factor, known coronary risk factors, are strongly associated with the formation of atherosclerotic plaques in rabbits. The plaques contain a considerable amount of fibrinogen related antigen.
Hernández
L R
LR
Instituto Venezolano de Investigaciones Científicas, Laboratorio de Fisiopatología, 1020 A, Caracas, Venezuela.
Lundberg
U
U
Arocha-Piñango
C L
CL
D000818:Animals; D001161:Arteriosclerosis / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D004036:Diet, Atherogenic; D005293:Ferritins / Q000032:analysis; D005340:Fibrinogen / Q000502:physiology*; D006400:Hematocrit; D006487:Hemostasis; D006937:Hypercholesterolemia / Q000097:blood; D007958:Leukocyte Count; D011817:Rabbits; D012307:Risk Factors; D018180:Thrombomodulin / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D017539:Tunica Intima / Q000378:metabolism / Q000473:pathology; D014841:von Willebrand Factor / Q000378:metabolism*
D018180:Thrombomodulin; D014280:Triglycerides; D014841:von Willebrand Factor; D005340:Fibrinogen; D005293:Ferritins